CLINICAL_TRIALS
trial_result
· 2018-02-19
Clinical Trial Update: Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children [Phase 2]
Summary
Phase 2 trial update assessing safety and immunogenicity of two malaria vaccines in Ghanaian children.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2018-02-19